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Objective. Although most patients recover from acute Q fever, around 20% develop Q fever fatigue syndrome (QFS), a debil-
itating fatigue syndrome that lasts at least 6 months. This study investigated transcriptional profiles of circulating monocytes and 
circulating cytokines as a subsequent mirror of myeloid cell function, 1 and 6 months after an acute Q fever infection.
Methods. Total RNA of circulating monocytes was collected from 11 acute Q fever patients and 15 healthy controls, matched for 
age (±5 years) and sex. Samples were collected at a median of 27 days (baseline, interquartile range, 15–35 days) after the infection 
and again 6 months thereafter. Transcriptome analysis was performed using RNA sequencing. Additionally, concentrations of circu-
lating interleukin (IL)-10, IL-1β, IL-1Ra, and IL-6 were measured in serum.
Results. At baseline, acute Q fever patients clearly show a differential transcriptional program compared with healthy controls. 
This is still the case at follow-up, albeit to a lesser extent. At baseline, a significant difference in levels of circulating IL-10 (P = .0019), 
IL-1β (P = .0067), IL-1Ra (P = .0008), and IL-6 (P = .0003) was seen. At follow-up, this difference had decreased for IL-10 (P = .0136) 
and IL-1Ra (P = .0017) and had become nonsignificant for IL-1β (P = .1139) and IL-6 (P = .2792).
Conclusions. We show that an acute Q fever infection has a long-term effect on the transcriptional program of circulating 
monocytes and, therefore, likely their myeloid progenitor cells, as well as concentrations of circulating IL-10, IL-1β, IL-1Ra, and IL-6.
Key words:  cytokine; monocytes; Q fever; Q fever fatigue syndrome; transcriptome.
INTRODUCTION
Q fever is a zoonosis caused by the obligate intracellular Gram-
negative bacterium Coxiella burnetii [1]. The bacterium mainly 
resides in animal reservoirs, such as cattle, goats, and sheep. The 
bacterium is shed in high numbers via birth products, urine, 
feces, and milk. Human infection usually occurs in outbreaks or 
endemic areas through inhalation of infected aerosols spread 
by the wind, or during at-risk veterinary or farming procedures 
[2]. Upon inhalation, it is thought that around 40% of patients 
develop a symptomatic infection (ie, acute Q fever), often 
presenting as a flu-like illness with fever and sometimes pneu-
monia or hepatitis [1]. Acute Q fever has an incubation period 
of 2 to 3 weeks and is usually treated with doxycycline 200 mg 
BID for 14 days despite it being an often self-limiting disease 
[1, 3]. During the infection, C. burnetii survives and replicates 
inside the phagolysosome of monocytes and macrophages 
it infects [1]. It has a pronounced effect on these cells as it is 
able to alter cellular processes (eg, vesicular trafficking, apop-
tosis, autophagy, and reactive oxygen species [ROS] and re-
active nitrogen species [RNS] production) by implementing 
a Dot/Icm type IV secretion system once inside the modified 
phagolysosome [4, 5].
Despite clearing the initial infection, approximately 20% of 
acute Q fever patients develop Q fever fatigue syndrome (QFS), 
a debilitating post-infective fatigue syndrome that lasts for at 
least 6 months and often years after initial infection [6]. QFS 
should be differentiated from chronic Q fever, or C. burnetii per-
sistent focalized infection, a deadly disease characterized by the 
persistence of C. burnetii in the human host, usually manifesting 
as endocarditis or infection of pre-existing aneurysms or vas-
cular prostheses [7]. Q fever fatigue syndrome often coincides 
with concomitant musculoskeletal complaints, neurocognitive 
problems, sleeping problems, headaches, (night) sweats, fre-
quently recurring upper respiratory tract infections, and mood 
disorders [6]. Like other post-infective fatigue syndromes, the 
exact etiology of QFS remains unclear. However, complaints, 
such as night sweats, musculoskeletal pain, and frequently 
applyparastyle “fig//caption/p[1]” parastyle “FigCapt”
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recurring upper respiratory tract infections, suggest an active 
role for the immune system. Furthermore, previous studies have 
shown signs of altered cell-mediated immunity through the in-
terferon (IFN)γ and interleukin (IL)-6 axis in these patients, 
even years after their initial infection [8–10]. Recently, it was 
found that monocytes and likely also myeloid progenitor cells 
are able to protract long-lasting immunologic memory (also 
termed “trained immunity”) following certain challenges, such 
as infectious agents and vaccines [11–13].
In order to increase our understanding of the long-term 
changes in the transcriptional and functional programming 
of myeloid cells during and after an acute Q fever infection, 
we investigated the transcriptomes of circulating monocytes 
in 11 acute Q fever patients at the time of infection and after 
6 months. Complaints suggestive of QFS were monitored and 
circulating cytokine profiles were also determined. The results 
were compared with 15 age- and sex-matched healthy controls.
METHODS
Study Population
The study population consisted of 11 acute Q fever patients and 
15 healthy controls that were matched for age (±5 years) and 
gender. At baseline, acute Q fever patients were diagnosed at 
the Australian Rickettsial Reference Laboratory based on their 
in-house serology (Immunofluorescence assay [IFA]). Serum 
samples of cases suspected for having an acute Q fever infection 
were sent in by physicians in Victoria (VIC) and New South 
Wales (NSW). If a sample showed positive immunoglobulin (Ig)
M antibody titers in the absence or with low IgG antibody titers, 
the treating physician of that patient was contacted, informed of 
the study, and asked for the patient’s contact information. The 
patient was then contacted by telephone by the primary inves-
tigator (R.R.), informed of the study, and asked to participate. 
If the patient gave oral informed consent, the primary inves-
tigator visited the patient, acquired written informed consent, 
collected blood, and asked the patient to fill out the Checklist 
Individual Strength (CIS) questionnaire, subscale on fatigue 
severity, and Sickness Impact Profile-8 (SIP-8) questionnaire. 
Finally, a follow-up visit 6 months afterwards was planned at 
which the above described procedure was repeated and patients 
were determined to have acquired QFS or not according to the 
Dutch guideline on QFS, minus an extensive clinical evaluation 
of underlying somatic or psychiatric comorbidity [14].
Healthy controls (ie, colleagues who lived in the Geelong 
(VIC) or Launceston (Tasmania) area) were asked to partici-
pate by the primary investigator (R.R.) during the same time as 
the patients if they tested negative on Q fever serology and had 
a score < 35 on the subscale fatigue severity of the CIS ques-
tionnaire and a score <  450 on the SIP-8 questionnaire both 
at baseline and at follow-up. All participants provided written 
informed consent and the study was approved by the Barwon 
Health Human Research Ethics Committee (#16/156).
Monocyte Isolation
A total of 40 ml EDTA blood was collected from each patient 
for peripheral blood mononuclear cell (PBMC) isolation, which 
was performed by dilution of blood in phosphate-buffered 
saline (PBS) (1:1), and fractions were separated by den-
sity centrifugation over Ficoll-Paque (Ficoll-Paque Plus; GE 
Healthcare, Zeist, the Netherlands). Cells were washed 3 times 
with cold PBS and resuspended in Roswell Park Memorial 
Institute (RPMI) 1640 Dutch modification culture me-
dium (Life Technologies/Invitrogen, Breda, the Netherlands) 
supplemented with 50  μg/mL gentamicin, 2  mM Glutamax, 
and 1  mM pyruvate (Life Technologies). Mean PBMC count 
following Ficoll-Paque isolation was 32.6 × 106 (standard error 
of the mean [SEM] ±5.6) and 22.4 × 106 (SEM ± 1.7) at base-
line, and 30.4 × 106 (SEM ± 3.7) and 22.3 × 106 (SEM ± 3.2) 
at follow-up, for patients and controls, respectively. Percoll iso-
lation of monocytes was performed as previously described 
[15]. Briefly, around 20–30 × 106 PBMCs were layered on top 
of a hyperosmotic Percoll solution (48.5% Percoll, 41,5% sterile 
H2O, 0.16 M filter sterilized NaCl), adjusted for PBMC count, 
and centrifuged for 15 minutes at 580 g. The interphase layer 
was isolated and cells were washed once with cold PBS. Cells 
were resuspended in culture medium as described above.
RNA Isolation and Quantification
RNA was isolated from the monocyte-enriched suspension 
using the mirVana™ miRNA Isolation Kit (Ambion, Austin, 
TX) according to the manufacturer’s instructions. The purity 
and quantity of RNA were assessed using NanoDrop soft-
ware  (Thermo Fisher Scientific, Waltham, MA), after which 
samples immediately were stored at −80°C for future use.
RNA Sequencing Alignment and Expression Analysis
RNA sequencing was performed on 11 acute Q fever patients 
and 15 healthy controls. RNA sequencing library data ini-
tially were subjected to a quality control step, where, based on 
read distribution over the annotated genome, libraries that are 
outliers were identified and discarded from further analysis. 
For expression analyses, reads were aligned to the Ensembl v68 
human transcriptome using Bowtie (John Hopkins University, 
Baltimore, MD). Quantification of gene expression was 
performed using MMSEQ (GitHub, San Francisco, CA).
Differential Expression
Analysis was performed using DESeq2, using as input the 
MMSEQ counts (Unique_hits) (Bioconductor, Fred Hutchinson 
Cancer Research Center, Seattle, Washington, DC). Only genes 
with average counts (all samples) above 1 were fed into the 
DESeq2 software. DESeq2 internally performs another round 
of independent filtering (usually, the filter threshold of average 
number of reads would be ~5). To check for the main source of 
variation, principal-component analysis (PCA) was performed 
on the top 500 varying genes.
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Differential Expression of MT-RNR1 and MT-RNR2
Based on recent findings by our group [16] identifying a signif-
icantly decreased expression of mitochondrial-derived peptide 
(MDP)-coding genes MT-RNR1 and MT-RNR2 in QFS patients 
compared with healthy controls, we investigated the expression 
of these genes in acute Q fever patients compared with healthy 
controls, both at the time of infection and follow-up.
Pathway Enrichment Analysis
For the analysis of over- and underrepresented biological 
pathways, comparing the various groups (n = 10), ClueGo ver-
sion 2.1.7 was used in the integrative bioinformatic software en-
vironment of Cytoscape version 3.2 (Institute of Systems Biology, 
Seattle, Washington, DC). Pathways were significantly overly 
expressed if they showed a P value ≤ .05, and only differentially 
expressed genes with a P value < .01 were selected for pathway anal-
ysis. Various analysis pathways, like Kyoto Encyclopedia of Genes 
and Genomes pathway, Reactome pathway, and Wikipathway, 
were used on the differentially expressed gene lists, followed by 
Benjamini-Hochberg adjustment for terms and groups. Enriched 
pathways are depicted as gene ontology terms.
Cytokine Assays
The Ella microfluidic analyzer (ProteinSimple, San Jose, CA) was 
used to assess circulating concentrations of interleukin (IL)-1β, TNFα, 
IL-6, IL-10, and IL-1Ra in serum. Due to sample loss, cytokines could 
be determined only in 9 out of 11 acute Q fever patients at baseline 
and 10 out of 11 acute Q fever patients at follow-up.
Determination of Altered Cytokine Responses of Naïve Monocytes 
Following Stimulation With C. burnetii
By determining production of IL-6 and TNFα in monocytes 
of healthy Q fever seronegative controls, isolated from buffy 
coats obtained from healthy volunteers (Sanquin Bloodbank, 
Nijmegen, the Netherlands), that either previously had been 
stimulated with Q fever antigen or a negative control, we 
investigated whether C.  burnetii is able to inflict long-lasting 
changes in monocyte cytokine responses. For this experiment, 
we employed the model of trained immunity [13].
Statistical Analysis
Data were analyzed using Graphpad Prism (version 5.03, Graphpad 
Software, Inc., San Diego, CA) and SPSS (version 22.0, SPSS, 
Inc., IBM Business Analytics, Armonk, NY). The Mann-Whitney 
test was used as nonparametric t test to determine differences be-
tween groups. Statistical significance was attained if P < .05.
RESULTS
Patients and Controls
Blood of acute Q fever patients was drawn at a median of 27 days 
(interquartile range , 15–35 days) after their last sick day (hereafter 
referred to as “baseline”), and again 6 months thereafter (hereafter 
referred to as “follow-up”). Healthy controls were matched for age 
(P = .95) and gender (Table 1). All acute Q fever patients showed signs 
of an acute or recent infection, reflected by phase 2 IgM antibodies 
in the absence of phase 1 IgG antibodies. All healthy controls had 
negative IgM phase I and II and IgG phase I and II titres, both at 
baseline and follow-up, showing no signs of a past or active Q fever 
infection. At follow-up, QFS was diagnosed in 2 patients from the 
acute Q fever group, according to the Dutch guideline on QFS [14] 
(Table 1). No patients showed signs of chronic Q fever reflected by 
IgG phase I antibody titres ≥ 1:800.
Circulating Cytokines
Circulating concentrations of IL-10, IL-1β, IL-1Ra, and IL-6 
were measured at baseline and follow-up. Compared with 
the healthy controls, acute Q fever patients had significantly 
higher concentrations of circulating IL-10 (median 5.81 pg/
ml versus 2.77 pg/ml, P = .0019), IL-1β (median 13.05 pg/ml 
versus 0.69 pg/ml, P  =  .0067), IL-1Ra (median 2132 pg/ml 
versus 512.4 pg/ml, P = .0008), and IL-6 (median 14.17 pg/
ml versus 1.81 pg/ml, P = .0003) at baseline (Figure 1A). At 
follow-up, this difference had decreased for IL-10 (median 
3.37 pg/ml versus 2.55 pg/ml, P = .0136) and IL-1Ra (median 
1121 pg/ml versus 413 pg/ml, P = .0017), and it had become 
nonsignificant for IL-1β (median 2.15 pg/ml versus 0.65 pg/
ml, P = .1139) and IL-6 (median 2.57 pg/ml versus 2.42 pg/
ml, P = .2792) (Figure 1B).
Table 1. Characteristics of Acute Q Fever Patients and Healthy Controls at Baseline and Follow-up
Baseline Follow-up
Characteristics Acute Q Fever (n = 11) Healthy Controls (n = 15) Acute Q Fever (n = 11) Healthy Controls (n = 15)
Male sex, n (%) 9 (82) 13 (87) — —
Age, y (median [IQR]) 46 (31–55) 47 (23–60) — —
Last sick day, daysa (median [IQR]) 27 (15–35) — — —
CIS subscale fatigue severity score, mean ± SD 41 ± 14 22 ± 8 20 ± 13 17 ± 6
SIP-8 total score, mean ± SD 721 ± 856 170 ± 214 277 ± 418 58 ± 134
QFS [RIVM guideline], number (%) — — 2 (18%) —
Abbreviations: CIS, Checklist Individual Strength questionnaire; IQR, interquartile range; QFS, Q fever fatigue syndrome; RIVM, the Netherlands’ National Institute for Public Health and the 
Environment; SD, standard deviation; SIP-8, Sickness Impact Profile-8 questionnaire.
a Last sick day indicates the day before time last sick.
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Principal-Component Analysis 
A PCA analysis was performed on the top 500 varying genes 
at baseline and follow-up. At baseline, the PCA plot clearly 
identifies the acute Q fever patients from the healthy controls, 
suggesting that monocytes of acute Q fever patients retain a 
strongly different transcriptional program for several weeks 
after the infection (Figure 2A). In contrast, the differences 
between patients and healthy volunteers were less strong at 
follow-up, although differences remained in an important per-
centage of patients (Figure 2B).
Heatmaps of Differentially Expressed Genes and Pathway Enrichment 
Analysis
A heatmap was made of genes that are differentially expressed 
in acute Q fever patients compared with healthy controls at 
baseline, using a cut-off P value  ≤  10 ×  10-10, and follow-up, 
using a cut-off P value ≤ 10 × 10–5 (Figure 3A), and in acute 
Q fever patients who recovered from their complaints (n = 9), 
compared with acute Q fever patients who developed QFS 
(n = 2), at baseline and follow-up, using a cut-off P value < .005 
(Figure 3B). Subsequent pathway enrichment analysis on 
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Figure 2. Principal Component Analysis of Top 500 Varying Genes Principal component analysis of RNA sequencing data obtained from the top 500 varying genes in 
unstimulated, circulating monocytes of acute Q fever patients and healthy controls at baseline (A) and 6-month follow-up  (B). Abbreviations: controls, healthy controls; 
patients, acute Q fever patients; PC, principal component.
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Figure 1. Circulating IL-10, IL-1β, IL-1Ra, and IL-6 of Acute Q Fever Patients and Healthy Controls at Baseline and Follow-up Levels of circulating IL-10, IL-1β, IL-1Ra, and 
IL-16 in acute Q fever patients and healthy controls at baseline (A) and 6-month follow-up (B). A, Baseline, a significant difference in levels of circulating IL-10 (P = .0019), 
IL-1β (P = .0067), IL-1Ra (P = .0008), and IL-6 (P = .0003) can be seen. B, Six-month follow-up, this difference has decreased for IL-10 (P = .0.136) and IL-1Ra (P = .0017) and has 
become nonsignificant for IL-1β (P = .1139) and IL-6 (P = .2792). Data are depicted as median ± interquartile range. Abbreviation: ns, nonsignificant.
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differentially expressed genes in acute Q fever patients at base-
line, using a cut-off P value  <  .001, and follow-up, using a 
cut-off P value <  .05, primarily exposed a down-regulation of 
pathways involved in energy metabolism and general epigenetic 
and transcriptional processes, together with an up-regulation 
of pathways involved in apoptosis and necrosis at baseline 
(Supplementary Table 1A). At follow-up, these differences were 
less pronounced and mainly consisted of an up-regulation of 
pathways involved in energy metabolism (Supplementary Table 
1B). A  table containing less prominently enriched pathways 
(P  >  .05  ≤  .001) at baseline is added as supplementary data 
(Supplementary Table 2).
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ANKRD28 0,00484 AC006116.15 0,00202 SNORA54 4,88E-11 GPR132 5,31E-14
GATA1 0,00486 ADGRG7 0,00207 SCARNA13 5,87E-11 SNIP1 6,06E-14
RP11-109G23.3 0,00491 AC012668.2 0,00223 CD1C 6,06E-11 CCDC93 6,17E-14
MTMR12 0,00498 PTGER3 0,00226 RNY1 7,23E-11 B4GALT5 6,39E-14
ADGRG3 0,00227 SNORA34 7,63E-11 TRIM38 6,50E-14
RN7SKP173 0,00228 EIF4A1 7,78E-11 KDM5A 6,53E-14
RP11-219G17.4 0,00229 NUP50 6,54E-14
RP11-296A18.5 0,00233 ZNF740 7,38E-14
AC116366.5 0,00234 BTN2A1 1,16E-13
IMMTP1 0,00235 USP47 1,22E-13
REPS2 0,00238 GBP5 1,33E-13
CMTM4 0,00238 ZNF615 1,47E-13
CTD-3220F14.1 0,00243 NFKB1 1,94E-13
LINC00029 0,00243 RHOU 2,19E-13
ECM2 0,00245 PRPF40A 2,70E-13
RP11-568G20.2 0,00252 ZNF654 3,03E-13
CSF3 0,00253 RNF185 3,25E-13
DOCK1 0,00256 TANK 4,15E-13
SULT1A1 0,00268 RBPJ 4,39E-13
ENSG00000251060 0,00284 UBE3A 4,91E-13
PADI2 0,00289 NFE2L2 7,04E-13
CAV1 0,00301 HARS2 8,62E-13
RP11-13A1.1 0,00302 CEP295 8,65E-13
ARG1 0,00304 NRBF2 8,65E-13
AXDND1 0,00308 TNFSF14 8,94E-13
RP11-404G16.2 0,00308 ZFP30 1,16E-12
PTGFR 0,00309 ZNF614 1,32E-12
SNORA47 0,00316 VWA9 2,08E-12
SMAD6 0,00321 CSTF1 2,13E-12
RANBP17 0,00326 TRAF3 2,32E-12
TAF7L 0,00327 CUL3 2,60E-12
CLIP1-AS1 0,00330 EIF2AK3 3,18E-12
GPX8 0,00331 RNF219 3,42E-12
SNX31 0,00335 CASP7 3,43E-12
MORF4L1P4 0,00337 UFL1 4,21E-12
RP11-131O15.2 0,00339 SPATA13 5,10E-12
AC073109.2 0,00345 ZNF227 5,38E-12
EIF1 0,00350 PPP1R16B 6,26E-12
RP11-930O11.2 0,00354 TP53RK 6,40E-12
CCDC175 0,00354 FAM175B 6,72E-12
RP3-496C20.1 0,00356 GPRIN3 8,57E-12
KCNN2 0,00359 PHF3 1,00E-11
IL5RA 0,00361 RANBP2 1,48E-11
RLIMP1 0,00363 CRK 1,64E-11
NUAK2 0,00367 RFWD3 1,87E-11
RP11-213H15.1 0,00383 TOR1AIP1 2,09E-11
AC011747.3 0,00383 SMURF2 2,11E-11
CTAGE13P 0,00388 TNRC6A 2,20E-11
MMP9 0,00397 IWS1 2,40E-11
MBOAT2 0,00398 PELO 2,65E-11
DIAPH2-AS1 0,00408 PHF23 2,71E-11
SLC19A1 0,00411 CHD1 2,93E-11
CNPY1 0,00420 ZNF45 3,02E-11
DNAJC22 0,00424 ETAA1 3,19E-11
C9orf72 0,00434 ZNF292 3,64E-11
TREM1 0,00434 MECP2 3,65E-11
KIR3DL3 0,00456 ERCC5 3,69E-11
RP11-349N19.2 0,00460 SECISBP2L 3,85E-11
SLC27A1 0,00464 S1PR1 4,31E-11
NR1H4 0,00466 RBM26 4,32E-11
NAMPT 0,00471 FBXO28 4,33E-11
TCP11L2 0,00473 CWC22 4,90E-11
RCN1P1 0,00479 APOL3 5,24E-11
ACE2 0,00495 IST1 5,71E-11
RP4-781K5.4 0,00496 GNL3 5,90E-11
STX6 6,65E-11
TAF5L 7,14E-11
TBC1D2B 7,46E-11
C3orf17 7,76E-11
DIS3 8,36E-11
DCLRE1C 8,38E-11
USP8 8,74E-11
ZNF17 8,79E-11
Range -0.5  −  -1.1 0.5  −  1.5 -0.4  −  -1.2 0.5  −  0.9 Range -0.7  −  -1.9 0.6  −  1.5 -0.4  −  -1.0 0.5  −  1.4
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Acute Q fever patients compared to healthy controls at baseline Acute Q fever patients compared to healthy controls at follow-up
Downregulated genes Upregulated genes Downregulated genes Upregulated genes
Recovered compared to non-recovered patients at baseline Recovered compared to non-recovered patients at follow-up
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Figure 3. Differential Gene Expression in Acute Q Fever Patients and Healthy Controls at Baseline and Follow-up Heatmaps showing differential expression of down- and 
up-regulated genes in circulating monocytes from acute Q fever patients compared with healthy controls at baseline and follow-up. A, Down- and up-regulated genes in 
9 acute Q fever patients who recovered from their complaints, compared with 2 who developed Q fever fatigue syndrome, using a cut-off P value < .005. B, Down- and 
up-regulated genes in 11 acute Q fever patients compared with 15 healthy controls at baseline, using a cut-off P value ≤ 10 × 10-10, and follow-up, using a cut-off P 
value ≤ 10 × 10–5. Heatmaps are based on level of differential expression, measured with log 2-fold change.
D
ow
nloaded from
 https://academ
ic.oup.com
/ofid/article-abstract/6/7/ofz296/5523799 by R
adboud U
niversity user on 14 O
ctober 2019
6 • ofid • Raijmakers et al
Altered Cytokine Responses of Naïve Monocytes Following Stimulation 
With C. burnetii
Monocytes that were initially stimulated with C. burnetii showed 
significant increase in the production of IL-6 and TNFα upon 
stimulation with LPS after 6 days compared to RPMI (P = .02 
and P = .03, respectively, Figure 4).
Differential Expression of MT-RNR1 and MT-RNR2
At baseline, both MT-RNR1 and Mt-RNR2 were less expressed 
in acute Q fever patients, compared with healthy controls 
(-0.7 log 2-fold change; P = .0111, and -0.9 log 2-fold change; 
P = .0002, respectively) (Figure 5). At follow-up, this difference 
was no longer observed. Furthermore, a decreased expression 
that was nonsignificant at baseline and follow-up of MT-RNR1 
(-0.1 log 2-fold change; P =  .2868 and -0.1 log 2-fold change; 
P = .5143, respectively) and MT-RNR2 (-0.3 log 2-fold change; 
P =  .6707 and -0.1 log 2-fold change; P =  .5209, respectively) 
was observed in the 2 acute Q fever patients who developed 
QFS compared with the 9 who recovered from their complaints.
DISCUSSION
This study investigated transcriptional profiles of circulating 
monocytes and cytokines as a mirror of myeloid cell function, a 
median of 27 days and 6 months after an acute Q fever infection. 
Previous studies have documented long-term reprogramming 
of myeloid cells by vaccinations, but no studies to date have 
demonstrated that similar effects may happen after human 
infections. It is hypothesized that due to long-term complications 
of acute Q fever, such as QFS, in which monocyte and macro-
phage products, such as pro-inflammatory cytokines, may play 
an important role, infection with C. burnetii may induce a long-
term functional reprogramming of myeloid cells. Indeed, we have 
observed important long-term effects of the Q fever infection on 
the monocyte transcriptome, an effect resembling trained immu-
nity reprogramming reported after vaccination with live vaccines 
[17]. The concept of changed myeloid cell function is further re-
inforced by the higher concentrations of circulating IL-10, IL-1β, 
IL-1Ra, and IL-6 in patients 1 month after the infection, with re-
sidual effects on IL-10 and IL-1Ra 6 months thereafter.
At a median of 27  days after the infection, an apparent 
down-regulation of pathways involved in energy metabolism 
and general epigenetic and transcriptional processes, together 
with an up-regulation of pathways involved in apoptosis and 
necrosis, was seen in acute Q fever patients compared with 
healthy controls. At follow-up, these differences had dimin-
ished and mainly consisted of an up-regulation of energy me-
tabolism. These results indicate that circulating monocytes can 
retain long-term alterations in their transcriptional program 
following an acute Q fever infection. It is likely that this tran-
scriptional reprogramming occurs at the level of progenitor 
cells in the bone marrow [18]. Similar findings in myeloid cells 
were made following exposure to live vaccines [19]. The live-
attenuated Bacillus Calmette-Guérin vaccine for instance is able 
to induce epigenetic reprogramming together with a metabolic 
shift that alters myeloid cell functionality and responsiveness to 
subsequent nonspecific infectious insults [11, 17, 19]. Marmion 
et al., hypothesized that QFS patients undergo chronic immune 
stimulation through persisting nonviable C.  burnetii antigens 
following the acute Q fever infection [20–22]. Such a process 
could very well explain long-term reprogramming of myeloid 
progenitor cells following an acute Q fever infection, especially 
if such antigens persist in the bone marrow [23]. It is of great 
interest to see that an infectious insult such as acute Q fever 
infection also is able to induce long-lasting reprogramming of 
myeloid cells. Together with the observations that in vitro pro-
duction of IL-6 and TNFα is increased in monocytes that were 
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Figure 4. C. burnetii Primes Production of Pro-inflammatory Cytokines by Monocytes Employing the model of trained immunity [13], we stimulated naïve monocytes of 
healthy controls with C. burnetii or RPMI culture medium as a negative control for 24 hours, washed away the stimulus, and let the cells rest for 6 days. After 6 days, cells 
were again stimulated for 24 hours, this time with either RPMI culture medium as a negative control or LPS as a nonspecific stimulus, ultimately investigating whether 
C. burnetii is able indeed to inflict long-lasting changes in monocyte cytokine responses. A, Monocytes previously exposed to C. burnetii (1x107/mL) produced significantly 
more IL-6 (P = .02) upon restimulation with LPS than naïve monocytes. B, Monocytes previously exposed to C. burnetii (1x107/mL) produced significantly more TNFα (P = .03) 
upon restimulation with LPS than naïve monocytes. Results are depicted as mean ± SEM. Experimental setup is based on the in vitro model of trained immunity [13] and 
included monocytes of 3 healthy controls in 2 independent experiments. Abbreviations: C.b., Coxiella burnetii; IL, interleukin; LPS, lipopolysaccharide; RPMI, Roswell Park 
Memorial Institute culture medium; SEM, standard error of the mean; TNF, tumor necrosis factor.
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primed with C. burnetii and later stimulated with a nonspecific 
stimulus, these results suggest that an acute Q fever infection 
is able to induce long-lasting functional reprogramming of 
myeloid cells.
Looking at circulating cytokines in acute Q fever patients 
compared with healthy controls, we found concentrations of 
IL-10, IL-1β, IL-1Ra, and IL-6 to be increased at baseline and to 
a lesser extent still at follow-up. This is an interesting finding as 
one would expect the concentrations of these cytokines to have 
normalized within a few weeks after the infection. It could be 
argued that the altered transcriptional programming of myeloid 
cells contributes to these long-lasting differences in circulating 
cytokine concentrations. The down-regulation in energy metab-
olism, epigenetic, and transcriptional processes, and the more 
specific repressive H3K9me2 on the promoter regions of both 
IL-6 and IL-8 at baseline, together with the down-regulation of 
interleukin signalling and up-regulation of energy metabolism 
at follow-up, are likely to contribute to these findings. A general 
but less prominent activation of Toll-like Receptor and cytokine 
signalling pathways at baseline, but no longer at follow-up, pos-
sibly also play a role (Supplementary Table 2).
It has long been thought that an inflammatory component 
contributes to the pathophysiology of QFS [8–10]. Previous 
studies found signs of altered immunity through the IFNγ 
and IL-6 axis in these patients. Furthermore, a recent study 
found that PBMCs of QFS patients produce higher amounts of 
TNFα, IL-1β, and IL-6 when stimulated with Q fever antigen. 
It also was shown that QFS patients had higher levels of cir-
culating IL-6 compared with healthy controls and higher levels 
of IFNγ compared with asymptomatic Q fever seropositive 
controls [24]. Looking at less prominently enriched pathways 
in our study (Supplementary Table 2), both TNFα and IFNγ 
signalling pathways are enriched at baseline, but no longer at 
follow-up. Given our findings on long-lasting changes in mon-
ocyte transcriptomes and circulating cytokine concentrations 
in acute Q fever patients, it could be argued that the pro-
inflammatory responses necessary for clearing the acute Q 
fever infection can linger, become detrimental, and take part in 
the pathophysiology of QFS [10]. Possible alterations in these 
processes likely are regulated through epigenetic remodelling 
of promoter regions of these cytokines genes in myeloid pro-
genitor cells, tissue macrophages, and, to a lesser extent, cir-
culating monocytes [11, 13]. It would be interesting to further 
investigate monocyte transcriptomes and specific epigenetic 
markers at the promoter regions of these cytokines during the 
development of QFS, starting at the acute Q fever infection. 
Moreover, reprogramming of resident tissue macrophages, like 
microglia, is of particular interest when investigating QFS and 
chronic fatigue syndrome (CFS) pathophysiology as this can 
drive low-grade neuroinflammation [25, 26]. It is plausible that 
an acute Q fever infection translates to similar reprogramming 
of microglia in the brain, either through mirroring of peripheral 
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Figure 5. Boxplots Showing Differential Expression of MT-RNR1 (A) and MT-RNR2 (B) in Acute Q Fever Patients Compared With Healthy Controls at Baseline Boxplots 
showing normalized counts of MT-RNR1 (A) and MT-RNR2 (B) in circulating monocytes in acute Q fever patients and healthy controls. Results are depicted as median ± in-
terquartile range.
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inflammation during the infection or long-lasting transcrip-
tional changes in myeloid progenitor cells [27, 28]. As recovery 
in acute Q fever patients was associated with a long-lasting 
anti-inflammatory cytokine profile (ie, IL-10 and IL-1Ra) and 
decreasing pro-inflammatory cytokine profile (ie, IL-6 and 
IL-1β), it would be of interest to investigate the dynamics of 
these and other cytokine profiles in the development of QFS.
At follow-up, 9 out of 11 patients had fully recovered while 
2 had developed QFS. At this time, both the transcriptional 
reprogramming and difference in concentrations of circu-
lating cytokines had diminished, indicating normalization 
of myeloid programming and functioning. This most likely 
reflects the normal recovery of most (ie, 9 out of 11) acute Q 
fever patients in this study. Although it should be noted that 
these numbers are insufficient for conducting reliable analyses, 
some differences in differentially expressed genes were found 
between these groups, both around the time of infection and 
6 months thereafter. As was previously described, no apparent 
difference in PCA is observed when comparing QFS patients 
with healthy controls [16]. A previous study, investigating lon-
gitudinal peripheral blood gene expression in postinfective fa-
tigue syndrome following Epstein-Barr virus, Ross River virus, 
and acute Q fever infections, concluded that no genes were con-
sistently correlated with the illness itself [29]. In this study, sev-
eral genes were selected that were associated with CFS in the 
past. No comparable results were found when looking at dif-
ferential expression in patients who developed QFS compared 
with patients who adequately recovered from their infection, 
likely due to insufficiently small numbers.
Finally, another interesting observation was the signifi-
cantly decreased expression of MDP-coding genes MT-RNR1 
(MOTS-c) and MT-RNR2 (humanin) 1 month after infection, 
but no longer after 6 months. Both MT-RNR1 and MT-RNR2 
were previously found to be significantly less expressed 
in circulating monocytes of QFS patients compared with 
healthy controls [16]. Interestingly, when comparing those 
who developed QFS with those who recovered from their 
acute Q fever infection, a general decreased expression, al-
beit not significant, of both MT-RNR1 and MT-RNR2 was 
observed both at baseline and follow-up. It could, therefore, 
be postulated that incentives such as an acute Q fever infec-
tion are able to negatively influence the expression of these 
MDP-coding genes in monocytes. Given the functions of 
MOTS-c and humanin [30–34], it is definitely worthwhile 
to further investigate the role of these MDP-coding genes in 
the pathophysiology of QFS and CFS.
Although this study makes an interesting observation that an 
acute Q fever infection can induce long-lasting reprogramming 
of circulating monocytes, it should be noted that small num-
bers were used and, due to logistical challenges, monocyte pu-
rity was not checked prior to transcriptome analysis. Further 
studies in larger groups are warranted in order to validate these 
interesting results. Using larger groups would additionally en-
able a better longitudinal comparison of acute Q fever patients 
who develop QFS with acute Q fever patients who recover from 
their complaints.
This study shows that an acute Q fever infection has a long-lasting 
effect on the transcriptional program of circulating monocytes 
and concentrations of circulating IL-10, IL-1β, IL-1Ra, and IL-6. 
It is postulated that the long-lasting effects on the transcrip-
tional program of monocytes, their myeloid progenitor cells, and 
concentrations of circulating cytokines become detrimental and 
play a part in the pathophysiology of QFS. Additionally, it was 
shown that an acute Q fever infection can result in a decreased 
expression of MDP-coding genes MT-RNR1 (MOTS-c) and 
MT-RNR2 (humanin), previously linked with QFS and CFS.
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the posted materials are not copyedited and are the sole responsibility of 
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